What a Brain Scan Can—and Cannot—Prove About Trauma

What a Brain Scan Can—and Cannot—Prove About Trauma

By J.Michelle

Imagine a reader interpreting a brain image as an authoritative answer to an experience that has been doubted: here is the injury; here is the cause; here is proof. This is a hypothetical interpretation to examine, not a finding about how readers generally respond.

CDC guidance distinguishes identifying concussion from using a CT scan when bleeding is a concern. [3] But a picture does not answer every question merely because it is a picture of the brain.

The Logue hippocampal study compares groups, while Gilbertson and colleagues examine a competing vulnerability interpretation. [1, 2] Those designs can identify patterns worthy of further study. They do not automatically validate an individual test for whether abuse occurred, who caused a finding, or whether a particular account is credible.

This distinction is especially important when interpreting regional volume differences. A group average cannot be translated into a statement that one person has lost a particular percentage of memory, intelligence, or future potential. For purposes of this editorial, possible pre-existing differences and exposure-related explanations are treated as unresolved alternatives rather than established causes.

Clinical scans also have different purposes. CDC guidance notes that concussion does not always require imaging, while CT may be used when concern about bleeding makes it appropriate. [3] A normal scan therefore should not be used as a universal declaration that nothing happened. [3] For an abnormal result, I recommend asking the clinician what the finding means and which questions remain unanswered.

Before paying for an imaging service marketed as a trauma answer, a reader can ask several practical questions. What exact condition is the test intended to identify? How was it validated for people like me? What are the limits and possible incidental findings? How would the result change treatment? Who will interpret it, and can they explain uncertainty without selling another package?

Begin with the question the scan is intended to answer

Imaging is most useful when its purpose is explicit. A clinician may be investigating a particular medical concern, while a research team may be comparing measurements across participants. Those are different uses. A reader should not assume that a finding produced for one purpose has been validated for every other question about trauma, injury, or personal history.

This distinction can be expressed simply: what decision would the result inform? If a proposed test is said to prove abuse, identify its perpetrator, or certify recovery, that claim needs evidence specific to that use. General statements that imaging reveals brain activity do not establish those much more demanding tasks. This article does not treat group studies as tests of individual credibility or event-specific causation.

A legitimate clinical question may still justify imaging. The argument here is not against scans; it is against unlimited claims for them. A test can be valuable within its scope while being unable to answer a question the patient understandably wants resolved. Explaining that limit is part of informed care, not a dismissal of the concern.

A hypothetical image with several possible interpretations

Imagine that a survivor receives a report describing a finding that is not specific to a single cause. They may connect it immediately to the most significant recent experience in their life. That connection is understandable, but the report and the life history still require clinical interpretation. A temporal association is not, by itself, a complete causal explanation.

Now consider a normal result. The person may conclude that their concentration problems cannot be real. CDC guidance explains why that conclusion is too broad for concussion: imaging is not always required for diagnosis, and clinical assessment includes more than a scan. [3] A normal result can answer the question the test was designed to investigate without resolving every symptom.

These hypothetical alternatives show why the meaning of a result should be discussed with the clinician. The patient can ask what was excluded or identified, what remains uncertain, and which next step is relevant. The aim is not to obtain whichever interpretation feels most validating. It is to understand how the finding fits the full assessment.

Research pictures are not individual biographies

In the hypothetical interpretation above, the reader treats a research association as a personal finding. Yet group studies combine variation across many people. Even when an average difference is statistically meaningful, it does not reveal the earlier structure of one participant's brain or establish that a named event caused the difference. The interpretation of hippocampal findings should preserve this causal limit. [1, 2]

The same limit applies to functional measures. A difference in task-related activity does not translate automatically into a percentage of lost ability, a permanent lesion, or a universal account of what trauma does. The task, participants, comparison, and analysis determine what can be concluded. Readers should be wary when the visual force of a figure replaces those details.

This is not a claim that research imaging lacks value. For this editorial, I propose interpreting research imaging in relation to the associations tested, the hypotheses posed, and the next research question, rather than treating it as a personal diagnostic verdict. Its value is strengthened when the interpretation remains faithful to the design. Turning every result into an individualized narrative of damage may make a headline stronger while making the science less accurate.

Evaluating a commercial offer

Suppose a service markets imaging as the missing explanation for a person's recovery difficulties. Before paying, the reader can ask which condition the test is intended to identify and what evidence supports that use in comparable patients. They can also ask who interprets the result, what uncertainty will be discussed, and how the result would change care. These are proposed consumer questions, not a judgement about a named provider.

A further issue is the relationship between testing and the service sold afterward. If the same business uses an image to justify a costly programme, the evidence for that programme still needs separate evaluation. A measurement and an intervention do not validate one another merely because they are offered together. Nor does a change in an image automatically establish an improvement meaningful to the person.

The financial question should remain visible without becoming the only question. A test may be expensive and appropriate, or inexpensive and uninformative. The relevant judgement concerns clinical purpose, validation, interpretation, alternatives, and burden. A sales promise should not replace that discussion, especially when the person is seeking relief from uncertainty.

The desire for proof deserves respect

Consider a hypothetical survivor who hopes a scan will make their experience undeniable. An article should acknowledge that desire without promising a tool more capable than the evidence shows. This editorial argues that dramatic visible evidence should not be a prerequisite for attending to reported symptoms and functional change. Care should not depend on obtaining an image that resembles a compelling illustration.

There is a countercondition: refusing to overstate imaging does not mean symptoms alone settle every causal or diagnostic question. This editorial proposes considering the report together with examination, history, appropriate tests, and other evidence. The distinction is between taking a concern seriously and claiming that one type of evidence answers everything.

A responsible account of imaging therefore preserves both its usefulness and its limits. Ask the clinical question first, interpret the result in context, and avoid converting a research association into a personal verdict. The person deserves an explanation accurate enough to guide care, rather than a picture asked to carry a story it cannot independently establish.

Implication for practice and interpretation

A report can contain a medically relevant finding without explaining the entire experience. The patient should be able to ask which conclusion follows directly from the image and which depends on the history or other assessment. I propose separating those statements so that the explanation explicitly identifies what was observed and what remains uncertain. This is a communication standard, not a demonstrated intervention effect. The proposed standard for communication is precise scope: explain the purpose, result, limitations, and practical consequence, then identify the concern that remains. A visually persuasive result should still be interpreted as evidence rather than as a complete biography.

Conclusion

These are questions about clinical usefulness, not an argument against imaging. The relevant question is what a particular imaging examination is intended and able to assess; CDC identifies concern about bleeding as one reason for CT assessment. [3] The concern here is treating these particular group studies as support for individualized or event-specific conclusions.

This editorial treats that hypothetical desire for visible proof respectfully. But access to care should not depend on obtaining a dramatic image. This editorial proposes considering a careful history, examination, and assessment of functional problems alongside imaging. Evidence is strongest when each tool is used for the question it can actually answer.

Evidence and disclosure

This is a research-informed educational editorial, not original empirical research or individual medical advice. Constructed examples are hypothetical. Practical applications are editorial proposals unless explicitly attributed to a tested intervention. Scientific claims are tied directly to the external sources listed below. No proprietary recovery efficacy is established. This manuscript was prepared with substantive AI assistance for literature synthesis and drafting. Five-year source exception ledger: Reference 1 (2018) is retained as a foundational multisite group study central to the discussion; Reference 2 (2002) is retained as a foundational study of the competing vulnerability interpretation.

References

1. Logue MW, et al. Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study. Biological Psychiatry. 2018;83(3):244-253. https://pubmed.ncbi.nlm.nih.gov/29217296/.

2. Gilbertson MW, et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nature Neuroscience. 2002;5(11):1242-1247. doi:10.1038/nn958. https://pubmed.ncbi.nlm.nih.gov/12379862/.

3. Centers for Disease Control and Prevention. About Mild TBI and Concussion. https://www.cdc.gov/traumatic-brain-injury/about/index.html.